Free Trial
NASDAQ:GBSN

(GBSN) (GBSN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.10
$0.12
50-Day Range
N/A
52-Week Range
$0.03
$18.00
Volume
104,097 shs
Average Volume
99,205 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBSN stock logo

About (GBSN) Stock (NASDAQ:GBSN)

Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.

GBSN Stock News Headlines

Creamy Roasted Red Pepper Dip
Supporting teachers
37 arrested in illegal gambling operations
Great Basin Scientific Inc (GBSNQ)
See More Headlines
Receive GBSN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (GBSN) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/22/2017
Today
5/30/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:GBSN
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • David Spafford (Age 55)
    Executive Chairman of the Board
  • Robert Jenison (Age 50)
    Senior Vice President - Research, Chief Technology Officer
  • Ryan Ashton (Age 56)
    President, Chief Executive Officer, Director
  • Kirk K. Calhoun (Age 73)
    Independent Director
  • Sam Chawla (Age 41)
    Independent Director
  • Ronald K. Labrum (Age 60)
    Independent Director

GBSN Stock Analysis - Frequently Asked Questions

How were (GBSN)'s earnings last quarter?

(GBSN) (NASDAQ:GBSN) announced its earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share (EPS) for the quarter. The medical research company had revenue of $0.85 million for the quarter.

When did (GBSN)'s stock split?

Shares of (GBSN) reverse split on the morning of Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 15th 2016. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of (GBSN) own?
This page (NASDAQ:GBSN) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners